Patent Assignment
Reel/Frame 052459/0278
Assignment of Assignor's Interest
Recorded: 2020-04-21
Pages: 48
Assignor
SARCODE BIOSCIENCE INC.
Executed: 2019-07-01
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Properties
(10)
Compositions and methods for treatment of diabetic retinopathy
Application:
60/999,571 →
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Application:
61/045,142 →
Delivery of Lfa-1 Antagonists to the Gastrointestinal System
Application:
61/045,165 →
Topical Lfa-1 Antagonists for Use in Localized Treatment of Immune Related Disorders
Application:
61/045,240 →
Aerosolized Lfa-1 Antagonists for Use in Localized Treatment of Immune Related Disorders
Application:
61/045,257 →
LFA-1 Inhibitor and Methods of Preparation
Application:
61/675,663 →
LFA-1 Inhibitor and Methods of Preparation
Application:
61/680,099 →
LFA-1 Inhibitor and Methods of Preparation and Polymorph Thereof
Application:
61/729,294 →
LFA-1 Inhibitor Formulations
Application:
61/739,609 →
Lfa-1 Inhibitor Formulations
Application:
61/758,147 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Apr 21, 2020
From: SARCODE CORPORATION
To: SARCODE BIOSCIENCE INC.
Reel/Frame 052458/0944 →
Change of Name
Apr 21, 2020
From: SARCODE CORPORATION
To: SARCODE BIOSCIENCE INC.
Reel/Frame 052459/0060 →
Assignment of Assignor's Interest
Oct 22, 2020
From: NOVARTIS AG
To: NOVARTIS PHARMACEUTICALS CORPORATION
Reel/Frame 054135/0165 →